174 related articles for article (PubMed ID: 33654013)
1. A Concept Analysis of Oral Anticancer Agent Self-management.
Mason M; Harris MR; Greer JA; Jiang Y
Cancer Nurs; 2022 Mar-Apr 01; 45(2):E374-E387. PubMed ID: 33654013
[TBL] [Abstract][Full Text] [Related]
2. To Improve Supportive Care for Patients Taking Oral Anticancer Agents.
He L; Song T; Jiang Y; Yu P; Song L; Gong Y
Stud Health Technol Inform; 2022 Jun; 290():547-551. PubMed ID: 35673076
[TBL] [Abstract][Full Text] [Related]
3. Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma.
Spees LP; Wheeler SB; Jackson BE; Baggett CD; Wilson LE; Greiner MA; Kaye DR; Zhang T; George D; Scales CD; Pritchard JE; Leapman M; Gross CP; Dinan MA
Cancer Med; 2021 Oct; 10(19):6653-6665. PubMed ID: 34480518
[TBL] [Abstract][Full Text] [Related]
4. Patient symptoms, self-management, and unscheduled healthcare use during the first 6 months of targeted oral anticancer agent therapy: protocol for a mixed-methods US study.
Rizvi-Toner A; Coe AB; Friese CR; Manojlovich M; Wallner L; Farris KB
BMJ Open; 2024 Feb; 14(2):e081375. PubMed ID: 38355181
[TBL] [Abstract][Full Text] [Related]
5. How adverse events and permanent medication stoppages affect changes in patients' beliefs about oral antineoplastic agents.
Marshall VK; Given CW; Sikorskii A; Given BA; Lehto RH
Support Care Cancer; 2020 Jun; 28(6):2589-2596. PubMed ID: 31529159
[TBL] [Abstract][Full Text] [Related]
6. Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents.
Ribed A; Escudero-Vilaplana V; Romero-Jimenez RM; Iglesias-Peinado I; Herranz-Alonso A; Sanjurjo-Saez M
Expert Opin Drug Saf; 2016; 15(4):427-35. PubMed ID: 26854363
[TBL] [Abstract][Full Text] [Related]
7. Photo elicitation, an approach to better understanding the patient experience with OAAs: pilot study and future implications.
Manojlovich M; Blok A; Wright N; Azhari E; Farris KB; Friese CR; Mackler E; Titler M; Byrnes M
Support Care Cancer; 2023 Oct; 31(12):652. PubMed ID: 37878093
[TBL] [Abstract][Full Text] [Related]
8. Patterns and Predictors of Oral Anticancer Agent Use in Diverse Patients With Metastatic Renal Cell Carcinoma.
Wheeler SB; Spees LP; Jackson BE; Baggett CD; Wilson LE; Greiner MA; Kaye DR; Zhang T; George D; Scales CD; Pritchard JE; Dinan MA
JCO Oncol Pract; 2021 Dec; 17(12):e1895-e1904. PubMed ID: 34138665
[TBL] [Abstract][Full Text] [Related]
9. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
[TBL] [Abstract][Full Text] [Related]
10. Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities.
González J; Quiroga M; Escudero-Vilaplana V; Collado-Borrell R; Herranz-Alonso A; Sanjurjo Sáez M
Expert Opin Drug Saf; 2018 Jun; 17(6):553-572. PubMed ID: 29781751
[TBL] [Abstract][Full Text] [Related]
11. The effect of a mobile application on treatment adherence and symptom management in patients using oral anticancer agents: A randomized controlled trial.
Karaaslan-Eşer A; Ayaz-Alkaya S
Eur J Oncol Nurs; 2021 Jun; 52():101969. PubMed ID: 33991868
[TBL] [Abstract][Full Text] [Related]
12. Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents.
Collado-Borrell R; Escudero-Vilaplana V; Ribed A; Jiménez RR; Peinado II; Herranz-Alonso A; Sanjurjo-Sáez M
Am J Health Syst Pharm; 2020 Aug; 77(17):1393-1402. PubMed ID: 32620958
[TBL] [Abstract][Full Text] [Related]
13. Secure Messaging, Diabetes Self-management, and the Importance of Patient Autonomy: a Mixed Methods Study.
Robinson SA; Zocchi MS; Netherton D; Ash A; Purington CM; Connolly SL; Vimalananda VG; Hogan TP; Shimada SL
J Gen Intern Med; 2020 Oct; 35(10):2955-2962. PubMed ID: 32440998
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA).
Farris KB; Cadwallader T; Farley J; Gatwood K; Mackler E; Gatwood J
Explor Res Clin Soc Pharm; 2022 Sep; 7():100163. PubMed ID: 35957656
[TBL] [Abstract][Full Text] [Related]
15. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
16. A Review and Conceptual Analysis of Cancer Pain Self-Management.
Durosier Mertilus DS; Lengacher CA; Rodriguez CS
Pain Manag Nurs; 2022 Apr; 23(2):168-173. PubMed ID: 34006496
[TBL] [Abstract][Full Text] [Related]
17. Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice.
Escudero-Vilaplana V; Revuelta-Herrero JL; Collado-Borrell R; Marzal-Alfaro B; Gimenez-Manzorro A; Herranz-Alonso A; Sanjurjo-Saez M
Expert Opin Drug Saf; 2019 Sep; 18(9):861-868. PubMed ID: 31282227
[No Abstract] [Full Text] [Related]
18. Self-management support for chronic disease in primary care: frequency of patient self-management problems and patient reported priorities, and alignment with ultimate behavior goal selection.
Hessler DM; Fisher L; Bowyer V; Dickinson LM; Jortberg BT; Kwan B; Fernald DH; Simpson M; Dickinson WP
BMC Fam Pract; 2019 Aug; 20(1):120. PubMed ID: 31464589
[TBL] [Abstract][Full Text] [Related]
19. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
[TBL] [Abstract][Full Text] [Related]
20. Outpatient oral anticancer agent utilization and costs in Manitoba from 2003 to 2016: a population-based study.
Leong C; Czaykowski P; Geirnaert M; Katz A; Dragan R; Yogendran M; Raymond C
Can J Public Health; 2021 Jun; 112(3):530-540. PubMed ID: 33471346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
